3-methylcrotonyl-CoA carboxylase 2 deficiency: genes and variants
Explore variant evidence for 3-methylcrotonyl-CoA carboxylase 2 deficiency across 1 analyzed protein (MCCC2). Linked ClinVar records include 46 pathogenic or likely pathogenic variants, 137 variants of uncertain significance and 27 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to 3-methylcrotonyl-CoA carboxylase 2 deficiency
MCCC2: Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial
It partners with MCCC1 to catalyze an essential carboxylation step in mitochondrial leucine catabolism. Biallelic pathogenic variants cause 3-methylcrotonyl-CoA carboxylase deficiency, which can produce hypoglycemia, acidosis, neurologic symptoms, or remain clinically mild.
46 ClinVar pathogenic / likely pathogenic and 164 uncertain variants in MCCC2 have source records linked to 3-methylcrotonyl-CoA carboxylase 2 deficiency. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to 3-methylcrotonyl-CoA carboxylase 2 deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MCCC2 R155Q | 155 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 A218T | 218 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 R155W | 155 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 H190Y | 190 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 R193H | 193 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 R193C | 193 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 A218V | 218 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 N403T | 403 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 N403S | 403 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 Y520S | 520 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 C167R | 167 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 R268T | 268 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 G352R | 352 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 Q477R | 477 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 G559D | 559 | Pathogenic / likely pathogenic (★★) | |
| MCCC2 S173L | 173 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 G214A | 214 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 D280Y | 280 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 V434L | 434 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 A524T | 524 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 T556A | 556 | Pathogenic / likely pathogenic (★★) | |
| MCCC2 I231F | 231 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 E99Q | 99 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 T139I | 139 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 P310R | 310 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 P397A | 397 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 N230D | 230 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 I437V | 437 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★★) |
| MCCC2 A218S | 218 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 P224L | 224 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 P224T | 224 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 Y520C | 520 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 L376P | 376 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 R394I | 394 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 Y318C | 318 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 A423D | 423 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 T556N | 556 | Pathogenic / likely pathogenic (★) | |
| MCCC2 Y23C | 23 | Pathogenic / likely pathogenic (★) | |
| MCCC2 A156V | 156 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 Y196H | 196 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 G237R | 237 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 A456P | 456 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 V481L | 481 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 T484P | 484 | CoA carboxyltransferase C-terminal | Pathogenic / likely pathogenic (★) |
| MCCC2 H190R | 190 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic |
| MCCC2 H266L | 266 | CoA carboxyltransferase N-terminal | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in 3-methylcrotonyl-CoA carboxylase 2 deficiency
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| MCCC2 R268G | 268 | CoA carboxyltransferase N-terminal | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; R268T at the same position is pathogenic; seen in 8.2e-06 of gnomAD DNA copies; REVEL 0.850 |
| MCCC2 V481M | 481 | CoA carboxyltransferase C-terminal | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; V481L at the same position is pathogenic; REVEL 0.930 |
| MCCC2 T556I | 556 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; T556N at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.61 | |
| MCCC2 P397R | 397 | CoA carboxyltransferase C-terminal | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; P397A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.96 |
| MCCC2 A524P | 524 | CoA carboxyltransferase C-terminal | Uncertain (★) | +6: in a 3D region that tolerates change poorly (3R); A524T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.92 |
Same protein, different disease
- 3-methylcrotonyl-CoA carboxylase deficiency also has ClinVar records linked to MCCC2 variants; they fall in the same places as the 3-methylcrotonyl-CoA carboxylase 2 deficiency variants (23 pathogenic / likely pathogenic).
Diseases related to 3-methylcrotonyl-CoA carboxylase 2 deficiency
- 3-methylcrotonyl-CoA carboxylase deficiency, also linked to MCCC2
Frequently asked questions
Which genes have records linked to 3-methylcrotonyl-CoA carboxylase 2 deficiency?
This view contains 1 analyzed proteins: MCCC2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 46 pathogenic or likely pathogenic variants, 137 variants of uncertain significance and 27 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 5 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 254 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center